Curate Biosciences Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.6M

  • Investors
  • 9

Curate Biosciences General Information

Description

Operator of a life science company intended to develop cell processing technologies and reduce the total vein-to-vein cost. The company's cell processing system allows a faster path to a cleaner and a larger quantity of starting cells, that gently isolate leukocytes using the fastest microfluidic technology, enabling healthcare professionals to obtain a larger quantity of healthier leukocytes compared to other separation technologies.

Contact Information

Formerly Known As
GPB Scientific
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Corporate Office
  • 2715 Loker Avenue West
  • Carlsbad, CA 92010
  • United States
+1 (442) 000-0000

Curate Biosciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curate Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Grant 31-Jan-2023 $3.6M 000.00 Completed Generating Revenue
19. Debt - General 31-Dec-2022 000 000.00 Completed Generating Revenue
18. Later Stage VC (Series C2) 31-Aug-2022 00.00 000.00 000.00 Completed Generating Revenue
17. Grant 19-Jul-2022 00000 000.00 Completed Generating Revenue
16. Later Stage VC (Series C2) 16-Apr-2021 0000 000.00 0000 Completed Generating Revenue
15. Later Stage VC (Series C1) 19-Mar-2020 000.00 000.00 0000 Completed Generating Revenue
14. Early Stage VC (Series B) 31-Jan-2020 00.000 000.00 000.00 Completed Generating Revenue
13. Grant 17-Apr-2018 00.000 000.00 Completed Pre-Clinical Trials
12. Grant 01-Apr-2018 $2.3M $10.1M Completed Pre-Clinical Trials
11. Accelerator/Incubator $10.1M Completed Pre-Clinical Trials
To view Curate Biosciences’s complete valuation and funding history, request access »

Curate Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C2 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 289,340 $0.000010 8% $7 $7 1x $7 2.93%
Series A 1,883,654 $0.000010 8% $4 $4 1x $4 19.08%
To view Curate Biosciences’s complete cap table history, request access »

Curate Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a life science company intended to develop cell processing technologies and reduce the total vein-to-vein co
Biotechnology
Carlsbad, CA
25 As of 2023
000.00
0000000000 000.00

000000

unt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000000000000
Ann Arbor, MI
00 As of 0000
000.00
0000000000 0 000.00

000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
00000000000 0000000
Santa Clara, CA
00 As of 0000
0000000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curate Biosciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akadeum Life Sciences Venture Capital-Backed Ann Arbor, MI 00 000.00 0000000000 0 000.00
Applied Cells Venture Capital-Backed Santa Clara, CA 00 0000000000 0
PluriSelect Formerly VC-backed Leipzig, Germany 0 00000 00000000000 00000
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany 0000 000000000
Fresenius Kabi Corporation Bad Homburg, Germany 00000
You’re viewing 5 of 5 competitors. Get the full list »

Curate Biosciences Patents

Curate Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220298476-A1 Methods for producing cell populations with increased nucleic acid uptake Pending 19-Mar-2021 0000000000 0
AU-2022209752-A1 Systems and methods for particle separation and concentration Pending 20-Jan-2021 000000000
EP-4281537-A1 Systems and methods for particle separation and concentration Pending 20-Jan-2021 000000000
CA-3204796-A1 Systems and methods for particle separation and concentration Pending 20-Jan-2021 000000000
JP-2024506485-A Systems and methods for particle separation and concentration Pending 20-Jan-2021 C12M23/16
To view Curate Biosciences’s complete patent history, request access »

Curate Biosciences Executive Team (8)

Name Title Board Seat Contact Info
David Backer Chief Executive Officer & Board Member
Jason Walsh Chief Financial Officer
Tony Ward Chief Technology Officer & Co-Chief Operating Officer
Joan Haab Co-Chief Operating Officer
Gaurav Vij Chief Business Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Curate Biosciences Board Members (10)

Name Representing Role Since
Daniel Getts Ph.D Self Board Member 000 0000
David Backer Curate Biosciences Chief Executive Officer & Board Member 000 0000
Justin Klein MD Vensana Capital Board Member 000 0000
Mayo Pujols Self Board Member 000 0000
Michael Grisham Curate Biosciences Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Curate Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curate Biosciences Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Vensana Capital Venture Capital Minority 000 0000 000000 0
Thylacine Capital Venture Capital Minority 000 0000 000000 0
Bio, Tech and Beyond Accelerator/Incubator 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Curate Biosciences FAQs

  • When was Curate Biosciences founded?

    Curate Biosciences was founded in 2002.

  • Who is the founder of Curate Biosciences?

    Edmund Ruffin Jr. and Michael Grisham are the founders of Curate Biosciences.

  • Who is the CEO of Curate Biosciences?

    David Backer is the CEO of Curate Biosciences.

  • Where is Curate Biosciences headquartered?

    Curate Biosciences is headquartered in Carlsbad, CA.

  • What is the size of Curate Biosciences?

    Curate Biosciences has 25 total employees.

  • What industry is Curate Biosciences in?

    Curate Biosciences’s primary industry is Biotechnology.

  • Is Curate Biosciences a private or public company?

    Curate Biosciences is a Private company.

  • What is Curate Biosciences’s current revenue?

    The current revenue for Curate Biosciences is 000000.

  • How much funding has Curate Biosciences raised over time?

    Curate Biosciences has raised $58.3M.

  • Who are Curate Biosciences’s investors?

    Amgen Ventures, Vensana Capital, Thylacine Capital, Bio, Tech and Beyond, and National Cancer Institute are 5 of 9 investors who have invested in Curate Biosciences.

  • Who are Curate Biosciences’s competitors?

    Akadeum Life Sciences, Applied Cells, PluriSelect, Miltenyi Biotec, and Fresenius Kabi are competitors of Curate Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »